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Abstract
Objective: Epidemiological evidence has linked consumption of black tea, produced from Camellia sinensis, with a reduced
risk of cardiovascular diseases. However, intervention studies on the effects of tea consumption on blood pressure (BP) have
reported inconsistent results. Our objective was to conduct a systematic literature review with meta-analysis of controlled
human intervention studies examining the effect of tea consumption on BP.
Methods: We systematically searched Medline, Biosis, Chemical Abstracts and EMBASE databases through July 2013. For
inclusion, studies had to meet the following pre-defined criteria: 1) placebo controlled design in human adults, 2) minimum
of 1 week black tea consumption as the sole intervention, 3) reported effects on systolic BP (SBP) or diastolic BP (DBP) or
both. A random effects model was used to calculate the pooled overall effect of black tea on BP.
Results: Eleven studies (12 intervention arms, 378 subjects, dose of 4–5 cups of tea) met our inclusion criteria. The pooled
mean effect of regular tea ingestion was 21.8 mmHg (95% CI: 22.8, 20.7; P = 0.0013) for SBP and 21.3 mmHg (95% CI: 2
1.8, 20.8; P,0.0001) for DBP. In covariate analyses, we found that the method of tea preparation (tea extract powders
versus leaf tea), baseline SBP and DBP, and the quality score of the study affected the effect size of the tea intervention (all
P,0.05). No evidence of publication bias could be detected.
Conclusions: Our meta-analysis indicates that regular consumption of black tea can reduce BP. Although the effect is small,
such effects could be important for cardiovascular health at population level.
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Introduction
Blood pressure is acknowledged to bear an independent
continuous relationship with the occurrence of cardiovascular
events [1]. Furthermore hypertension is recognised as the leading
global risk factor for mortality [2]. Considering this, even relatively
small reductions in population blood pressure can be considered of
major interest to public health [2–4].
A high dietary flavonoid intake has been linked to a reduced risk
of CVD [5], possibly through effects on BP and endothelial
function [6,7]. Black tea, produced by fermentation of the leaves of
Camellia sinensis, is the major source of dietary flavonoids in many
countries [8–10].
Epidemiological data support a link between black tea
consumption and a reduced risk of CVD [11]. Possibly, a BP
lowering effect may contribute to the reduced risk of CVD
associated with regular tea consumption [12], although results
from intervention studies examining effects of tea on BP are
inconsistent [13–19]. Indeed, previous meta-analyses have found
no significant effect of black tea consumption on BP [16,19].
Several high quality randomized controlled trials have however
been published since [13–15,17,18]. Our objective was therefore
to perform an up-to-date systematic review with meta-analysis of
controlled human intervention studies investigating the effects of
black tea consumption on BP.
Methods
This systematic review and meta-analysis was conducted in
accordance with the Preferred Reporting Items for Systematic
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e103247
Reviews and Meta-Analyses (PRISMA) statement guidelines. The
associated checklist (Checklist S1) can be found in the supporting
information section.
Search strategy
The Medline, Biosis, Chemical Abstracts and EMBASE
databases were searched (from the date of inception until July
2013) to identify potentially relevant studies conducted in human
adults and published in the English language. Titles, abstracts and
keywords were searched for the following terms: Tea, black tea,
flavonoid(s), tea extract(s), tea component(s), tea solid(s), camellia
sinensis, blood pressure, hypertension, hypertensive, hypotension,
hypotensive, endothelium, endothelial function, endothelial dys-
function. Bibliographies from obtained publications were searched
for additional potentially relevant studies.
Selection of trials
To qualify for inclusion, studies had to meet the following pre-
defined inclusion criteria: 1) randomized controlled trial in human
adults; 2) use of freshly brewed black tea or black tea powder
produced by drying freshly brewed tea (not purified or isolated
substances from tea) for $ 1 week; 3) reported effects on SBP or
DBP or both, along with measures of variability; 4) no intentional
co-intervention from which the effect of tea could not be isolated.
We followed a two-step process for selection of studies to be
included in the meta-analysis. During the first step, titles, abstracts
and keywords of publications were screened to identify potentially
eligible studies. During the second step, the full texts of these
publications were examined to gauge eligibility based on the
abovementioned inclusion criteria. Eligibility was assessed sepa-
rately by two authors (AG and RD). In case of discrepancy,
eligibility was discussed among authors until consensus was
reached.
Data extraction
After eligible publications were identified, the following
information was extracted: 1) publication details (author, year of
publication, country); 2) study design characteristics (crossover or
parallel, blinding, duration); 3) subject characteristics (age, BP
medication use, gender and health status); 4) treatment charac-
teristics (type and dosage of tea, type of control); 5) BP
measurement characteristics (office or ambulatory BP); 6) SBP
and DBP data (including measures of variance), and 7) charac-
teristics needed to gauge study quality. If any of the required data
Figure 1. Flow diagram of the study selection procedure.
doi:10.1371/journal.pone.0103247.g001
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were not reported, the authors of the publication in question were
approached in order to obtain it (successful in three occasions
[14,17,20]).
Quality assessment
Assessment of methodological quality was done by means of a
tool based on the Delphi Consensus [21] that we had previously
developed [22]. Because of the subjective nature of quality
assessments like this, we decided a priori to not use the obtained
quality scores for excluding or weighing studies in the meta-
analysis. We however examined the association between method-
ological quality and effect size.
The extent of heterogeneity in results between studies was
assessed by using the Cochran’s Q statistic (with P,0.1 considered
to represent statistically significant heterogeneity) and the I2-
statistic (with 25% considered to be low-level heterogeneity, 25%–
50% moderate-level heterogeneity, and .50% high-level hetero-
geneity) [23,24].
Publication bias was evaluated by means of visual inspection of
funnel plots (constructed by plotting inverse standard errors (SE)
against the respective SBP and DBP effects for each trial) and
Egger’s regression test [25].
Statistical analysis
For parallel studies, the change in BP was calculated as the
change from baseline in the intervention group subtracted from
the change from baseline in the control group. For cross-over
studies, the change in BP was calculated as the difference between
BP at the end of intervention period and BP at the end of the
control period. The study of Grassi et al. [13] measured both office
and 24-hour ambulatory BP in one control and four treatment
periods (each with an increasing dose of tea). To ensure that the
weight of this small study was not disproportionately large, we
averaged the effects of the four treatments into a single value. The
office and ambulatory BP outcomes of this study [13] were entered
separately into the analysis, but we halved the weights in these
arms so that the office and ambulatory BP outcome each
contributed 50% of the overall weight of the study.
The pooled effect and corresponding 95% CIs were calculated
by means of fixed and random effects models [26,27]. Since a
random effects model with studies weighted by the inverse of their
variance (1/SE2) results in a more conservative estimate of
statistical significance, this served as the primary model. If SE’s of
the change in BP were not reported, they were derived from P-
values or calculated according to the equations by Follmann et al.
[28] assuming a within-subject correlation coefficient of 0.68 [19].
To test whether a particular study was exerting excessive
influence on the results, we conducted influence analysis by
systematically excluding each study one-by-one and then reana-
lyzing the remaining data. We also explored the potential effects of
pre-defined covariates on the overall outcome by calculating
pooled BP effects for different subgroups of dichotomous
covariates (only if subgroups consisted of .4 study arms), and
by performing weighted meta-regression [29,30] for continuous
covariates. The pre-defined covariates were mean baseline BP
(using BP of the control group at the end of the trial period to
avoid regression to the mean), dose of tea flavonoids, type of tea
(leaf tea or standardized powder), type of placebo (caffeine
controlled, yes or no), duration and quality. Calculations were
done using the PROC MIXED model of the SAS analytical
system (SAS v9.2, SAS Institute, Cary, NC, USA).
Results
The systematic searches yielded a total 866 potentially relevant
publications (Figure 1). After exclusion of irrelevant publications
and studies that did not meet the pre-defined inclusion criteria, 9
studies remained. Two additional eligible studies were published
after the conduct of the systematic search [14,18], yielding a total
of 11 studies (12 study arms) that were included in our meta-
analysis. Trial characteristics are summarized in Table 1.
A total of 378 subjects participated in the 11 studies. The
number of subjects per study ranged from 13 to 95. Mean age
ranged from 33 to 73 years and mean BMI from 24 to 30 kg/m2.
One study included only men [13]; in the remaining studies, the
percentage of male subjects ranged from 26% to 78%. Five of the
11 studies included healthy normotensive populations. The other
studies included coronary artery disease patients [31], hypertensive
subjects [14,20], subjects at high cardiovascular risk [17] and
subjects with mildly elevated blood pressure [32] and cholesterol
[33]. Mean baseline SBP and DBP ranged from 120 to
150 mmHg and from 72 to 92 mmHg, respectively.
Seven studies used a cross-over design and 4 studies a parallel
design. Study duration ranged from 1 week to 6 months. The dose
of tea consumption in the intervention arms ranged from 400 to
1800 mL per day, providing an estimated 240 to 1500 mg of
flavonoids per day. Six of the 11 studies provided intervention
products in the form of leaf tea that subjects had to infuse in a
defined amount of hot water (200 to 300 mL) for a defined time
period (1 to 2 min). In the remaining 5 studies, tea was prepared
by dissolving standardized doses of tea extract powder in hot
water. In three studies [13–15], the control treatment was matched
for appearance, taste and caffeine content of the tea interventions,
whereas in two studies [32,34] this was done only for caffeine
content. In the remaining six studies [17,18,20,31,33,35], the
control treatment was plain hot water.
Pooled SBP effects showed moderate heterogeneity (P = 0.11,
I2 = 35%) between studies, whilst there was no evidence for
heterogeneity in DBP effects (P = 0.26, I2 = 20%). In the pooled
analyses using random effects models, tea intake reduced SBP with
1.8 mmHg (95% CI: 22.8, 20.7; P = 0.0013) and DBP with
1.3 mmHg (95% CI: 21.8, 20.8; P,0.0001). The overall
estimates of BP effects were similar when using fixed effects
models (22.0 and 21.3 mmHg for SBP and DBP, respectively)
(Figure 2 A & B).
In covariate analyses (Table 2), studies using tea extract
powders found larger reductions in SBP than studies using leaf
tea. Baseline SBP and DBP had a significant impact on the effect
of tea ingestion on BP, with a ,1 mmHg larger reduction for
every 10 mmHg higher baseline SBP and DBP respectively.
Interestingly, each 1-point increase in the perceived quality score
of the studies was associated with a 1 mmHg larger reduction in
the DBP effect estimate. The covariate analysis found no
substantial influence of amount of tea flavonoids, controlling for
caffeine content, or the duration of the intervention.
Figure 2. Net changes in SBP (A) and DBP (B) in randomized studies of black tea consumption. Horizontal lines represent 95% confidence
intervals. Grey diamonds represent the pooled estimates using fixed and random effects models respectively. Grassi et al. 2009 reported both office
and ambulatory BP – both sets of data were included in the analyses, but to keep the weight of the study proportionate, the weight of each arm was
halved.
doi:10.1371/journal.pone.0103247.g002
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Figure 3. Funnel plots of trials included in the meta-analysis for (A) systolic blood pressure and (B) diastolic blood pressure.
doi:10.1371/journal.pone.0103247.g003
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Omitting each study from the analysis to check for dispropor-
tionate impact of a single study did not materially affect results for
SBP or DBP. Pooled estimates ranged from 21.3 to 22.2 mmHg
and 21.2.to 21.5 mmHg for SBP and DBP respectively and
remained statistically significant in all cases. Visual inspection of
Funnel plots did not indicate the presence of publication bias and
this was supported by the outcome of Egger’s linear regression test
(intercept: 0.56; P = 0.45 for SBP and intercept: 0.76; P = 0.37 for
DBP) (Figure 3 A and B).
Discussion
This meta-analysis, summarizing evidence from 11 randomized
controlled intervention studies including 378 subjects, found that
daily consumption of black tea for $ 1 week is associated with a
statistically significant reduction in SBP and DBP of 2 and
1 mmHg, respectively. Although these reductions in BP are
modest from an individual’s perspective, such reductions are
relevant on a population-wide scale and may translate to
substantial reductions in CVD risk [3,4]. Moreover, we found
that the effect of tea ingestion was more pronounced in those with
a higher a priori baseline BP. In fact, data from the Prospective
Studies Collaboration indicate that a 2 mmHg lower SBP is
associated with a 10% lower stroke mortality and about 7% lower
mortality from ischemic heart disease or other vascular causes in
middle age subjects [3]. Therefore, our findings provide a possible
explanation for the reductions in risk for stroke observed in
epidemiological studies on tea consumption [36–38].
Our rationale for conducting this meta-analysis was the recent
publication of a number of high-quality randomized controlled
trials, which could appreciably change the outcomes from previous
meta-analyses and the general consensus from those analyses that
tea may not impact BP. Three of the newly included studies
reported statistically significant effects [13–15]. These studies had
well-standardized interventions, robust double-blind designs with
repeated BP measurements and low variances causing them to
contribute a large amount of weight to the analysis. This explains
our observation of a relation between the perceived quality score
of the studies and the reported effect size of tea on BP. More
specifically, studies with higher quality scores generally reported
lower BP variances which mean higher statistical power to detect
statistically significant reductions in BP after tea intake. It is thus
important for future studies on tea and BP to achieve the highest
possible level of quality.
A biological mechanism that could, at least in part, explain the
BP lowering effect of black tea relates to the influence of black tea
flavonoids on endothelial function. Previous studies found that
endothelial function shares a complex relationship with hyperten-
sion and it has been suggested as an early marker for BP changes
[39]. Human intervention studies consistently indicate that black
tea consumption improves endothelial function as measured by
brachial artery flow mediated dilation (FMD) [22], most likely
through improved bioavailability of nitric oxide (NO) [40,41].
Accordingly, the decrease in BP after daily tea ingestion may be, at
least partly, mediated through an improvement in endothelial
function, which may contribute to a lowering in peripheral
vascular resistance.
The magnitude of the effect of tea ingestion on BP may be
dependent on baseline BP. We found that each 10 mmHg higher
baseline SBP was associated with a 1 mmHg larger SBP effect size
and a similar association was seen for DBP. The dependence of
treatment effect size on baseline BP has been reported previously
[42–45]. This would imply that individuals with a higher resting
BP and therefore higher risk for CVD would benefit most from
measures to reduce BP, including tea consumption. This
observation might have been due to the regression to the mean
effect since it is known to be a serious confounder in blood
pressure studies. Our statistical approach should have avoided this
however and the control and intervention arms of the studies
included in our analyses were well matched for baseline BP levels.
Our study found no evidence for a substantial influence of the
duration of the intervention or the amount of daily flavonoid
intake on the BP effect. Kay et al. meta-analyzed data from 77
studies of various flavonoid sources (tea, but also chocolate, red
wine, berries or grapes and flavonoid extracts) to relate BP and
FMD effects with flavonoid contents. In agreement with our study,
no dose-response relation could be detected between flavonoid
intake and BP [7]. In the American Cancer Society’s CPS-II
Nutrition Cohort, McCullough et al. found nonlinear associations
between flavonoid intake and fatal CVD, with lower risk already
apparent in the second intake quintile [46]. Combined with our
current meta-analysis, this suggests that beneficial effects of
flavonoid-rich foods like black tea on BP and CVD risk could be
already attained at moderate intake levels.
Several limitations of this meta-analysis should be noted. Firstly,
the majority of the included studies had relatively small sample
sizes, potentially leading to publication bias and overestimation of
treatment effects, because smaller trials might be methodologically
less robust and are prone to report larger effect sizes [47,48].
However, we could not detect evidence of systematic publication
bias in our analysis although such bias can never be fully ruled out.
Secondly, only three of the included studies were double-blinded.
It is well possible that detection bias has occurred in the other
studies where the subjects and, in some cases, the investigators
were not blinded as to the treatments. Interestingly, in our analysis
a larger effect size of tea ingestion on BP was related with a high
quality rating. This indicates that the BP lowering effect of tea
estimated here cannot be simply explained by the inclusion of the
un-blinded, lower quality studies. Finally, the outcomes of the
covariate analyses on factors influencing the BP effect of tea should
be interpreted with caution because our meta-analysis included a
relatively small number of studies, and was therefore not suited to
reliably estimate the impact of potential covariates.
In conclusion, this review provides an up-to-date overview of
controlled human intervention studies on the effects of black tea
consumption on BP. Our analysis indicates that daily consumption
of 4 to 5 cups of black tea can reduce BP by 1–2 mmHg. Although
this effect is modest, it may be of importance for cardiovascular
health at the population level because of the widespread
consumption of black tea and the high prevalence of hypertension
and consequent risk of CVD.
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